Tissue microarray (TMA) technology is a high-throughput research tool, which has greatly
facilitated and accelerated tissue analyses by in-situ technologies. TMAs are amenable to …

Tissue microarrays (TMAs) are means of combining tens to hundreds of specimens of tissue
onto a single slide for analysis at one time. TMAs are most frequently constructed from …

Over the past few years, tissue microarray (TMA) technology has been established as a
standard method for assessing the expression of proteins or genes across large sets of …

A rapidly increasing number of genes are being suspected to play a role in cancer biology.
To evaluate the clinical significance of newly detected potential cancer genes, it is usually …

Traditionally, screening for new markers involves using a slide from each of several different
patients. A more efficient way is to have one slide that contains several minute specimens …

Since the original description in 1998, the tissue microarray technique (TMAs) has gained
widespread use as a fast and cost-effective method for molecular profiling of large numbers …

The tissue microarray (TMA) is the embodiment of high-throughput pathology. The platform
combines tens to hundreds of tissue samples on a single microscope slide for interrogation …

Several “high throughput methods” have been introduced into research and routine
laboratories during the past decade. Providing a new approach to the analysis of genomic …

Tissue microarray (TMA) is a recently implemented, high-throughput technology for the
analysis of molecular markers in oncology. This research tool permits the rapid assessment …

Recent research in molecular biology has identified a significant number of novel markers,
which may have diagnostic, prognostic and therapeutic significance. This is particularly …